The present invention provides methods and pharmaceutical compositions for treating ocular disorders associated with elevated intraocular pressure, such as glaucoma, by administering anti-epileptic or anti-convulsant compounds of the succinimide family, in particular compounds of formula I and/or II as defined herein.